News & Comment

Internet exchanges suggest an easy route to sourcing and licensing technology, but can biotech intellectual property be packaged up and sold in this way?

Before taking other people's money to finance your venture, it pays to fully educate yourself about the strings attached.

Branding is one of the most important and powerful aspects of building a business, but it requires delicate maintenance to keep it working for you instead of against you.

Business negotiations can be tricky, but with the help of some specialized software the process can be streamlined.

Holding the valuation high ground allows a biotech company to get the most value from potential partners. Here is how to establish and defend financial valuation.

Without credibility, everything you say to investors, potential partners or even your employees can be questioned. Here's how to build and retain it.

For entrepreneurs developing innovative technology, the platform business model is making a comeback.

What are the core elements of a successful biotech?

With thousands of biotech companies out there, and just as many corporate presentations, here's how to differentiate your enterprise in an increasingly crowded marketplace.

More and more collaborations are born from partnering meetings, but the size and hectic pace of these events can be overwhelming. To make the most of your time, go in prepared.

Whether your lab lease has expired or it's simply time for more space, moving entails more than just boxes and duct tape.

With the major economies around the world in recession, what strategic actions should you be taking?

Obviousness is one of the most common reasons for examiners rejecting patent applications. What can you do to limit the chances of such a setback?

Of all the ingredients in a biotech start-up, getting the right people involved is most crucial. Here, Ian Brown, CEO of SDP Technology, provides pointers for putting together a successful business team.

As a company grows, the founding scientist sometimes discovers (and investors often hint) that it's time to leave the CEO spot and hand it to someone with more business experience. To ease the possible shock of the process, consider this transition from day one.

Intellectual property (IP) is a critical asset at most life science start-up companies. Savvy organizational management of IP strategies and assets is essential in optimizing IP value as a sustainable business is built.

A young biotech firm can grow in several ways. The key to success is preparing for them all.

Understanding why licensing works in biotech, and why deals are structured as they are, will help the entrepreneur negotiate.

Intellectual property (IP) is often the most valued asset of biotech firms, especially startups. Two IP lawyers offer guidance on avoiding suits altogether, when to settle them and when to fight.

Biotech companies can extract unexpected value from their patent portfolios to remove roadblocks on the path to commercialization and success.